Ganciclovir
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
- Treatment of CMV retinitis (IV) in immunocompromised pts.
- Prophylaxis and prevention of CMV disease recurrence in pts with AIDS and solid organ transplant recipients (use for primary prophylaxis in HIV is FDA approved but not currently recommended; valganciclovir preferred).
- Herpes keratitis (ophthalmic gel)
NON-FDA APPROVED USES
- Castleman’s disease (limited data)
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
- Treatment of CMV retinitis (IV) in immunocompromised pts.
- Prophylaxis and prevention of CMV disease recurrence in pts with AIDS and solid organ transplant recipients (use for primary prophylaxis in HIV is FDA approved but not currently recommended; valganciclovir preferred).
- Herpes keratitis (ophthalmic gel)
NON-FDA APPROVED USES
- Castleman’s disease (limited data)
There's more to see -- the rest of this topic is available only to subscribers.